Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
08/2014
08/21/2014US20140234322 Thrombopoietin mimetics for the treatment of radiation or chemical induced bone marrow injury
08/21/2014US20140234320 Modulators of 4-1bb and immune responses
08/21/2014US20140234319 Treatment of heart failure and related conditions
08/21/2014US20140234318 Tumor specific oligosaccharide epitopes and use thereof
08/21/2014US20140234317 Methods for preventing toxic drug-drug interactions in combination therapies comprising anti-erbb3 agents
08/21/2014US20140234316 Vaccibodies targeted to cross-presenting dendritic cells
08/21/2014US20140234315 scFv Antibodies Which Pass Epithelial and/or Endothelial Layers
08/21/2014US20140234314 Antibodies against epidermal growth factor receptor (egfr) and uses thereof
08/21/2014US20140234313 Soluble polypeptides
08/21/2014US20140234312 Inhibition of tumor metastasis
08/21/2014US20140234310 Compositions and methods for treatment of bacterial and mycobacterial infections
08/21/2014US20140234309 Antibody-mediated transduction of heat shock proteins into living cells
08/21/2014US20140234308 Treatment of breast cancer with companion diagnostic
08/21/2014US20140234307 Method of treating multiple sclerosis by intrathecal depletion of b cells and biomarkers to select patients with progressive multiple sclerosis
08/21/2014US20140234306 Agent and Method for Reducing Inflammatory Markers
08/21/2014US20140234304 Human tissue factor antibody and uses thereof
08/21/2014US20140234303 Treatment of neurological conditions
08/21/2014US20140234302 Methods and Compositions for Reducing Amyloid Beta Levels
08/21/2014US20140234301 Modulation of PILR to Treat Immune Disorders
08/21/2014US20140234300 Method of modulating the activity of functional immune molecules
08/21/2014US20140234299 Therapies for chronic renal failure using one or more integrin antagonists
08/21/2014US20140234298 Therapeutic combinations of anti-cd20 and anti-gm-csf antibodies and uses thereof
08/21/2014US20140234297 Antibody constant domain regions and uses thereof
08/21/2014US20140234296 Stable formulations of antibodies to human programmed death receptor pd-1 and related treatments
08/21/2014US20140234294 Fibroblast Growth Factor Receptor-Derived Peptides Binding to NCAM
08/21/2014US20140234292 Process for Producing a Plasma Protein-Containing Medicament
08/21/2014US20140234291 Genetic polymorphisms associated with rheumatoid arthritis, methods of detection and uses thereof
08/21/2014US20140234222 Use of tnf alpha inhibitor for treatment of erosive polyarthritis
08/21/2014US20140234221 Antigen-binding proteins comprising recombinant protein scaffolds
08/21/2014US20140234218 Modified variable domain molecules and methods for producing them b
08/21/2014US20140234215 J591 minibodies and cys-diabodies for targeting human prostate specific membrane antigen (psma) and methods for their use
08/21/2014US20140234214 Methods of Treating a Tauopathy
08/21/2014US20140234213 Rationally-Designed Anti-Mullerian Inhibiting Substance Type II Receptor Antibodies
08/21/2014US20140234209 Chimeric and humanized anti-histone antibodies
08/21/2014US20140234208 Dual variable domain immunoglobulins and uses thereof
08/20/2014EP2767588A1 Use of rodent to produce hybrid antibodies contaning human variable region and rodent constant or FC region
08/20/2014EP2767549A1 Anti-CD26 antibodies and uses thereof
08/20/2014EP2767548A2 Modified IgG molecules
08/20/2014EP2766397A1 Improved assembly of bispecific antibodies
08/20/2014EP2766396A1 Anti-spla2-v antibodies and uses thereof
08/20/2014EP2766395A1 Antibody polypeptides that antagonize cd40l
08/20/2014EP2766394A1 Treatment for rheumatoid arthritis
08/20/2014EP2766393A1 ANTI-HtrA1 ANTIBODIES AND METHODS OF USE
08/20/2014EP2766392A1 A method for purifying antibodies
08/20/2014EP2766391A1 Canine/feline cd20 binding epitope and compositions for binding thereto
08/20/2014EP2766382A1 Meditopes and meditope-binding antibodies and uses thereof
08/20/2014EP2766042A1 ANTIBODIES TO CD1d
08/20/2014EP2766040A2 Uses for and article of manufacture including her2 dimerization inhibitor pertuzumab
08/20/2014EP2766039A1 Compositions for the treatment of rheumatoid arthritis and methods of using same
08/19/2014US8809509 Protein purification method
08/19/2014US8809508 Diagnostic antibody assay
08/19/2014US8809507 SPARC binding ScFvs
08/19/2014US8809506 Antibodies and vaccines for use in therapeutic and diagnostic methods for α-synuclein-related disorders
08/19/2014US8809503 Optimized Fc variants and methods for their generation
08/19/2014US8809502 Mutated anti-CD22 antibodies with increased affinity to CD22-expressing leukemia cells
08/19/2014US8809501 Nucleophilic catalysts for oxime linkage
08/19/2014US8809320 Benzodiazepine derivatives
08/19/2014US8809280 Therapeutic peptides
08/19/2014US8809051 Transgenic mammals having human Ig loci including plural VH and Vκ regions and antibodies produced therefrom
08/19/2014US8809005 Conjugate and its use as a standard in an immunoassay
08/19/2014US8809004 Detection of feline immunodeficiency virus
08/19/2014US8809002 MUC1, caspase-8, and DED-containing proteins
08/19/2014US8808999 Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereof
08/19/2014US8808705 Polyvalent chimeric OspC vaccinogen and diagnostic antigen
08/19/2014US8808701 Methods of inhibiting the interaction of C5aR with C5a with anti-C5aR antibodies
08/19/2014US8808700 Use of TNF alpha inhibitor for treatment of erosive polyarthritis
08/19/2014US8808697 Methods of use of soluble CD24 for therapy of rheumatoid arthritis
08/19/2014US8808691 Method for treating tumors and their metastases
08/19/2014US8808667 Method for generating active antibodies against a resistance antigen, antibodies obtained by said method and their uses
08/19/2014CA2651285C Methods and compositions for treatment of human immunodeficiency virus infection with conjugated antibodies or antibody fragments
08/19/2014CA2614972C Human anti-b7rp1 neutralizing antibodies
08/19/2014CA2595939C Methods of predicting therpeutic response in atopic dermatitis to il-31 antagonists
08/19/2014CA2552882C Methods for diagnosis and prognosis of cancers of epithelial origin
08/19/2014CA2506668C Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor
08/19/2014CA2490659C Humanized anti-tag-72 cc49 for diagnosis and therapy of human tumors
08/19/2014CA2482718C Derivatives of the il-2 receptor gamma chain, their production and use
08/14/2014WO2014124457A1 Methods for producing antibodies
08/14/2014WO2014124316A2 Specific sites for modifying antibodies to make immunoconjugates
08/14/2014WO2014124156A1 B cell lineage based immunogen design with humanized animals
08/14/2014WO2014124026A1 Immuno imaging agent for use with antibody-drug conjugate therapy
08/14/2014WO2014123696A1 Compositions for selective reduction of circulating bioactive soluble tnf and methods for treating tnf-mediated disease
08/14/2014WO2014123486A1 Methods for reducing aggregate levels in protein preparations by treatment with thio-heterocyclic cations
08/14/2014WO2014122660A1 Cd14 inhibitors as an effective treatment for hcv infection
08/14/2014WO2014122613A1 Anti-il-17a antibodies and their use in treating autoimmune and inflammatory disorders
08/14/2014WO2014122529A1 Immuno imaging agent for use with antibody-drug conjugate therapy
08/14/2014WO2014122298A1 Interleukin-4 inhibitors for the treamtent of neutropenia
08/14/2014WO2014122220A1 Induction of cross-reactive cellular response against rhinovirus antigens
08/14/2014WO2014122183A1 Muscarinic acetylcholine receptor binding agents and uses thereof
08/14/2014WO2014122144A1 BISPECIFIC ANTIBODIES AGAINST CD3ε AND BCMA
08/14/2014WO2014122143A1 Method for the selection of antibodies against bcma
08/14/2014WO2014121715A1 25-hydroxyl vitamin d detection kit and preparation method therefor
08/14/2014WO2014121325A1 Il-11r binding proteins and uses thereof
08/14/2014WO2014096248A3 Biomarker methods and compositions
08/14/2014US20140228547 Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)
08/14/2014US20140228546 Serum albumin binding proteins
08/14/2014US20140228545 Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)
08/14/2014US20140228544 Constructs and libraries comprising antibody surrogate light chain sequences
08/14/2014US20140228289 Modified and stabilized gdf propeptides and uses thereof
08/14/2014US20140228277 Peptide inhibitors of bace1
08/14/2014US20140228238 Genes and polypeptides relating to breast cancers
1 ... 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 ... 1494